EUVIMEDEUVIMED entdecken
Crossref

Immunometabolism mRNA expression phenotypes and reprogramming of CD14 in T2DM with or without CVD

Imen Bendaya, Awatef Ben Jemaa, Ghada Sahraoui, Maher Kharrat, Wissem Sdiri, Ridha Oueslati

International Immunopharmacology · 2023

DOI: 10.1016/j.intimp.2023.110665 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Immunopharmacology, 2023. Verfasst von Imen Bendaya und 5 weiteren Autor:innen. Beteiligte Einrichtung: Unit of Immunology and Microbiology Environmental and Carcinogenesis [IMEC], Faculty of Sciences of Bizerte, Zarzouna7021, University of Carthage, Bi…. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Cardiovascular Diseases. Die Arbeit nennt 60 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND/AIM: Type 2 diabetes mellitus (T2DM) and cardiovascular diseases (CVD) have a significant impact on the expression of genes in peripheral blood mononuclear cells (PBMCs). The primary objective of this study was to investigate the role of two signaling pathways, STAT1/6, and two important modulators of immunometabolism, leptin and PPARs, in the development of T2DM with and without CVD. Furthermore, the study aimed to assess the correlation between these factors and the dynamics of CD14 in PBMCs. This research was conducted within the context of a growing body of literature on the complex pathophysiology of T2DM and its association with CVD. Prior studies have indicated that T2DM is characterized by an imbalance in immunometabolism and the involvement of various signaling pathways. MATERIALS AND METHODS: Blood samples were collected from a total of 47 subjects, including 7 healthy volunteers, 20 individuals diagnosed with diabetes and cardiovascular disease (D.CVD) and another 20 individuals diagnosed with diabetes only (D). PBMCs were isolated from these samples, and the expression levels of leptin, PPARγ, PPARα, and CD14 genes were measured using Real-Time PCR. RESULTS: The most relevant result showed that diabetic patients with CVD had significantly higher levels of leptin expression, which was positively correlated with STAT1 (r = 0.7497, p = 0.0001). On the other hand, diabetic patients without CVD had elevated PPARγ expression, which was strongly correlated with STAT6 (r = 0.8437, p = 0.0001). Interestingly, we found a significant increase in the PPARγ/ PPARα ratio in the D.CVD group compared to the D group (4.273 ± 0.9531; 7.52 ± 3.556, p = 0.0479). Moreover, CD14 expression was significantly reduced in this group compared to diabetic patients without CVD. CONCLUSION: These findings suggested that the immunometabolic imbalance in T2DM was driven by a STAT1/Leptin phenotype in diabetic patients with CVD and by a STAT6/PPARγ phenotype in diabetic patients without CVD. Taking into account STAT1/Leptin and STAT6/PPARγ profiling could help clinicians identify novel therapeutic targets for T2DM and other related diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 2Cardiovascular DiseasesHumansLeptinPPAR gammaLeukocytes, MononuclearPPAR alphaPhenotypeRNA, Messenger

Stichwörter der Autor:innen

CD14ImmunometabolicLeptinPPARγPhenotypeSTAT1STAT6T2DM

Substanzen

LeptinPPAR gammaPPAR alphaRNA, Messenger

Autor:innen und Institutionen

  • Unit of Immunology and Microbiology Environmental and Carcinogenesis [IMEC], Faculty of Sciences of Bizerte, Zarzouna7021, University of Carthage, Bizerte, Tunisia. Electronic address: kefi.imen@gmail.com.
  • Unit of Immunology and Microbiology Environmental and Carcinogenesis [IMEC], Faculty of Sciences of Bizerte, Zarzouna7021, University of Carthage, Bizerte, Tunisia; Department of Biology, Faculty of science of Gafsa ,Un…
  • Department of Pathology, Salah Azaeiz Institute, Bab Saadoun 1006 Tunis, Tunis, Tunisia.
  • Laboratory of Human Genetics, Faculty of Medicine of Tunis, University of Tunis El Manar, Tunis, Tunisia.
  • Department of Cardiology, University Hospital Habib Bougatfa of Bizerte, Bizerte, Tunisia.
  • Unit of Immunology and Microbiology Environmental and Carcinogenesis [IMEC], Faculty of Sciences of Bizerte, Zarzouna7021, University of Carthage, Bizerte, Tunisia.

Zitieren

APA

Bendaya, I., Ben Jemaa, A., Sahraoui, G., Kharrat, M., Sdiri, W., & Oueslati, R. (2023). Immunometabolism mRNA expression phenotypes and reprogramming of CD14 in T2DM with or without CVD. International Immunopharmacology. https://doi.org/10.1016/j.intimp.2023.110665

Vancouver

Bendaya I, Ben Jemaa A, Sahraoui G, Kharrat M, Sdiri W, Oueslati R. Immunometabolism mRNA expression phenotypes and reprogramming of CD14 in T2DM with or without CVD. International Immunopharmacology. 2023. doi:10.1016/j.intimp.2023.110665

BibTeX
@article{Bendaya2023,
  author = {Bendaya, Imen and Ben Jemaa, Awatef and Sahraoui, Ghada and Kharrat, Maher and Sdiri, Wissem and Oueslati, Ridha},
  title = {Immunometabolism mRNA expression phenotypes and reprogramming of CD14 in T2DM with or without CVD},
  journal = {International Immunopharmacology},
  year = {2023},
  doi = {10.1016/j.intimp.2023.110665}
}
Kostenlos starten →